EMBASE project update: 100,000 records screened!

30 janvier 2015

Dear all,It has been a little while since we last updated on the project and now that 2014 has come to an end, it seems a good opportunity to relay some of the key events of the year and our plans for the future.As of the end of December 2014, 746 people have signed up; we've identified more than 4000 RCTs/q-RCTs, and screened 104,000 records!Those are metrics I think we can all feel very proud of.

Announcing Cochrane's new brand identity

30 janvier 2015

Image I am delighted to announce the launch of Cochrane’s new website and organizational identity.

Best of the Cochrane Library: 2014 in review

30 janvier 2015

Image Every Cochrane Image

Cochrane Review compares two drugs used for treatment of macular degeneration

30 janvier 2015

Image Cochrane Review shows how a cheaper alternative to licensed drug for treating eye disease has similar side effectsNeovascular macular degeneration is a progressive and chronic disease of the eye, and a leading cause of blindness in older people globally.

Teen smoking and e-cigarettes

30 janvier 2015

Image In a recent story, US-based Fox News discusses the publication of a number of major studies, including a Cochrane Review, a

Website for the 2015 Colloquium is now live!

30 décembre 2014

Image The website for the 23rd Cochrane Colloquium, taking place in Vienna from 3-7 October 2015, is now live. Get the latest information on key dates, registration, and activities in the historic host city.

Tamiflu and Relenza: getting the full evidence picture

8 mai 2014

Since 2002, governments around the world have spent billions of dollars stockpiling neuraminidase inhibitors (NIs) such as Tamiflu® (oseltamivir) and Relenza® (zanamivir) in anticipation of an influenza pandemic. This